Working… Menu

An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04708314
Recruitment Status : Terminated (The Sponsor has decided to focus their resources on other areas of therapy.)
First Posted : January 13, 2021
Last Update Posted : May 17, 2021
Sarepta Therapeutics, Inc.
Information provided by (Responsible Party):
Rare Disease Research, LLC

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 13, 2021
Actual Study Completion Date : May 13, 2021